The Oncology Institute, Inc. (NASDAQ:TOI) Shares Acquired by FreeGulliver LLC

FreeGulliver LLC raised its holdings in shares of The Oncology Institute, Inc. (NASDAQ:TOI) by 219.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 600,747 shares of the company’s stock after buying an additional 412,578 shares during the quarter. FreeGulliver LLC’s holdings in Oncology Institute were worth $186,000 as of its most recent filing with the Securities and Exchange Commission.

Separately, HighTower Advisors LLC lifted its stake in Oncology Institute by 190.8% during the 3rd quarter. HighTower Advisors LLC now owns 81,362 shares of the company’s stock valued at $27,000 after acquiring an additional 53,382 shares during the period. Institutional investors own 36.86% of the company’s stock.

Oncology Institute Stock Performance

Shares of NASDAQ TOI opened at $0.83 on Wednesday. The company has a current ratio of 2.49, a quick ratio of 2.27 and a debt-to-equity ratio of 5.91. The Oncology Institute, Inc. has a 12 month low of $0.13 and a 12 month high of $1.89. The company has a 50 day simple moving average of $0.74 and a two-hundred day simple moving average of $0.44. The stock has a market cap of $62.54 million, a price-to-earnings ratio of -1.06 and a beta of 0.41.

Oncology Institute Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.